Efficacy, safety, and predictive model of Palbociclib in the treatment of HR-positive and HER2-negative metastatic breast cancer

Abstract Purpose This research designeded to: 1. Analyze the efficacy and safety of Palbociclib treatment in HR-positive and HER2-negative (HR + /HER2-) metastatic breast cancer(MBC) patients. 2. Establish and validate a nomogram model for predicting the progression-free survival (PFS) rates of 6 mo...

Descrición completa

Detalles Bibliográficos

Principais autores:	Wei Wang, Wenqian Lei, Ziru Fang, Ruiyuan Jiang, Xiaojia Wang
Formato:	Artigo
Idioma:	Inglês
Publicado:	BMC 2024-01-01
Series:	BMC Cancer
Assuntos:	HR + /HER2- breast cancer Palbociclib Predictive model Nomogram Prognosis
Acceso en liña:	https://doi.org/10.1186/s12885-023-11764-8
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!